Hernday Natasha
Insider CIK 1780547 · ALPN Director · JANX Director · XOMA Director · PDLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 4,881 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 5,101 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 13,251 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 10,967 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 8,996 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer | 2026-07-14 | 2026-07-14 | 4,000 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | J Other | 2026-07-14 | 2026-07-14 | 9,304 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 15,500 | — | $0 | 15,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2026-06-11 | 2026-06-12 | 5,500 | — | $0 | 15,481 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2026-05-21 | 2026-05-26 | 3,586 | — | $0 | 12,592 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 11,667 | — | $0 | 11,667 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2025-06-11 | 2025-06-13 | 3,750 | — | $0 | 8,731 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2025-05-21 | 2025-05-23 | 5,971 | — | $0 | 9,006 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-07-19 | 2024-07-22 | 16,700 | — | $0 | 16,700 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-07-19 | 2024-07-22 | 8,350 | — | $0 | 8,350 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-07-19 | 2024-07-24 | 4,111 | — | $0 | 4,111 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-07-19 | 2024-07-22 | 2,500 | — | $0 | 7,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-07-19 | 2024-07-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-07-19 | 2024-07-24 | 1,231 | — | $0 | 6,231 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 15,000 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2024-05-15 | 2024-05-17 | 4,881 | — | $0 | 4,881 | SEC↗ |
| XOMA XOMA Corp | A Award | 2024-05-15 | 2024-05-17 | 3,035 | — | $0 | 3,035 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 10,967 | — | $0 | 10,967 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2022-05-18 | 2022-05-20 | 8,996 | — | $0 | 8,996 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2021-05-19 | 2021-05-21 | 5,101 | — | $0 | 5,101 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2021-01-04 | 2021-01-05 | 7,650 | — | $0 | 7,650 | SEC↗ |
| XOMA XOMA Corp | A Award | 2020-12-15 | 2020-12-17 | 4,000 | $25.00 | $100.0K | 4,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2020-12-10 | 2020-12-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2020-08-19 | 2020-08-24 | 118,671 | $3.63 | $430.8K | 118,671 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2020-08-19 | 2020-08-24 | 25,826 | — | $0 | 75,826 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2020-06-30 | 2020-07-02 | 13,251 | — | $0 | 13,251 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2019-06-20 | 2019-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |